Abstracts

• Abstracts (300 words in length) should contain the following four components: 1) Background: a concise statement of the issue under investigation or a hypothesis; 2) Methods: the methods used (including the statistical analyses employed); 3) Results: specific findings (promises such as “to be completed” or “to be presented” are not acceptable; no figures or tables); and 4) Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as “the results will be discussed” are not acceptable).
• Submitters will be asked several questions about their abstract that will enable the Scientific Committee to ensure it is reviewed appropriately. The questions pertain to topics such as the primary population of focus, gender, age group, geographic area of study, setting, disease/infection, methodology, and analytic approach.  Carefully read through the entire Abstract Classification list before submitting your abstract to ensure that your submission is read by the appropriate review team.
• Do not include grant acknowledgements, literature references, or copyright or trademark symbols.
• Multiple abstracts reporting results from the same study and overlapping abstracts from the same group of investigators are strongly discouraged.

• Abstracts (300 words in length) should contain the following three components: 1) Introduction: briefly introduce the case and its clinical relevance; 2) Case Description: describe in sequence the history, physical examination, clinical and laboratory investigation, diagnosis and patient course; and 3) Discussion: review decisions and lessons from the case, and implications for clinical care or public health relevance.
• Submitters will be asked several questions about their abstract that will enable the Scientific Committee to ensure it is reviewed appropriately. The questions pertain to topics such as the primary population of focus, gender, age group, geographic area of study, setting, disease/infection, methodology, and analytic approach. Carefully read through the entire Abstract Classification list before submitting your abstract to ensure that your submission is read by the appropriate review team.
• Do not include grant acknowledgements, literature references, or copyright or trademark symbols.
• Multiple abstracts reporting results from the same study and overlapping abstracts from the same group of investigators are strongly discouraged.

Investigators are invited to submit abstracts which describe clinical cases of STIs or STI-associated syndromes. These cases should comprise interesting, unusual, or complex presentations of STI, or should represent key teaching points that highlight emerging aspects of STI-related care. The cases will be presented to, and discussed by, an expert panel of clinicians who will review salient issues of epidemiology, clinical presentation, differential diagnosis, and management options. Cases should reflect recent patient encounters which highlight the complexities of STI clinical decision-making in current practice.